Related Experiment Videos
[Complicated malaria tropica--therapy with artemether]
1Abteilung für Innere Medizin, Deutschen UN-Krankenhauses Phnom Penh, Kambodscha.
Wiener Medizinische Wochenschrift (1946)
|January 1, 1994
Summary
Artemether, a new antimalarial drug, effectively treated severe Plasmodium falciparum malaria in 5 patients. This blood schizontocide rapidly reduced fever and improved consciousness, offering a promising treatment option.
Area of Science:
- Tropical Medicine
- Infectious Diseases
- Pharmacology
Background:
- Severe malaria, particularly Plasmodium falciparum infections, presents significant treatment challenges.
- Existing antimalarial drugs face issues with resistance and efficacy, necessitating novel therapeutic agents.
- Complications such as cerebral, pulmonary, and haemolytic issues require intensive management.
Observation:
- Five malaria patients in a German UN-hospital in Cambodia with severe Plasmodium falciparum infections were treated.
- Intramuscular artemether, a synthetic Qinghaosu derivative, was administered in combination with established antimalarials.
- Patients received supportive care including mechanical ventilation, blood transfusions, and metabolic monitoring.
Findings:
- All five patients survived and showed rapid improvement, with fever resolution and regained consciousness within 48–72 hours of artemether administration.
- Artemether demonstrated rapid schizontocidal activity against Plasmodium falciparum.
- The combination therapy was well-tolerated and effectively managed severe malaria complications.
Implications:
- Artemether represents a well-tolerated and rapidly effective blood schizontocide for severe malaria.
- To prevent recrudescence and mitigate drug resistance, artemether should be co-administered with tetracycline and a secondary schizontocide.
- This approach holds potential for improving malaria treatment outcomes in endemic regions and challenging clinical settings.